Bystronic (BYS) H2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
H2 2024 earnings summary
20 Dec, 2025Executive summary
Net sales declined 30.3% year-over-year to CHF 648.3 million, with order intake down 21.2% to CHF 625.4 million, driven by challenging markets, economic uncertainties, and internal execution issues.
Operating loss was CHF 84 million, with restructuring and impairment costs of CHF 36.6 million; adjusted EBIT was -CHF 47.4 million.
Net result for the year was -CHF 67.6 million, compared to a profit of CHF 41.9 million last year.
Restructuring program launched in September 2024 targeted annual savings of over CHF 60 million and a reduction of more than 600 FTEs.
Dividend proposal of CHF 4.00 per Class A share, down from CHF 12.00, reflecting negative results and future confidence.
Financial highlights
Service business declined 10.6%, while systems business fell 37.0% year-over-year; service now about a third of net sales.
Gross margin declined by 1.2 percentage points to 42.3%, though improved sourcing and service mix provided some offset.
Personnel expenses reduced by 8.3% (CHF 21 million); operating expenses down 13% to CHF 176 million.
Operating free cash flow remained positive at CHF 1.2 million, supported by working capital optimization.
Equity ratio strong at 69% of total assets; liquid assets at year-end were CHF 323 million.
Outlook and guidance
2025 expected to be a transition and consolidation year with continued market challenges and a weak start; no recovery anticipated.
Order intake expected to increase in H2 2025, mainly from market share gains, positively impacting 2026 net sales.
Two-thirds of cost savings from restructuring to be realized in 2025; only minor restructuring costs remain.
Net sales and operating profit expected to be slightly lower and negative, respectively, in 2025.
EBIT margin target of 5%-7% on organic net sales of around CHF 800 million over the cycle.
Latest events from Bystronic
- Order intake and profitability improved, with higher sales and further gains expected in 2026.BYS
H2 202526 Feb 2026 - Order intake and sales fell nearly 30%, leading to a record EBIT loss and no recovery expected.BYS
H1 20243 Feb 2026 - Order intake stabilized, EBIT loss narrowed 66%, and CHF 60m cost savings are on track.BYS
H1 202516 Nov 2025 - Order intake stable, sales down, with improved operating results expected for 2025.BYS
Q3 2025 TU23 Oct 2025 - Order intake and sales dropped over 25% as restructuring accelerates amid weak demand.BYS
Q3 2024 TU13 Jun 2025